|Articles|May 12, 2023
Pharma 2023: Vaccines Journey to the Consumer
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
Advertisement
At Pharma 2023 in Barcelona, Stefan Merlo, Vice President, Commercial Development at CSL Seqirus, discussed the global vaccine journey, the connected customer experience and the role of consumer and government education to improve public health.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Launch is Just the Beginning: Rare Disease Care Requires Durability
2
Novartis to Layoff 322 NJ Employees: Report
3
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
4
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
5